Emerging receptor target in the pharmacotherapy of irritable bowel syndrome with constipation

Expert Review of Gastroenterology and Hepatology

Volumn 7, Issue 5 SUPPL. 1, 2013, Pages 15-19

  Blackshaw, L Ashley ^a,b,c   Brierley, Stuart M ^a,b  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b ROYAL ADELAIDE HOSPITAL   (Australia)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Abdominal pain; Constipation; Cyclic GMP; Guanylate cyclase C; Irritable bowel syndrome; Linaclotide

Indexed keywords

BETA 3 ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLECYSTOKININ RECEPTOR BLOCKING AGENT; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; CYCLIC GMP; GUANYLATE CYCLASE; GUANYLATE CYCLASE C; LINACLOTIDE; SEROTONIN 1A ANTAGONIST; SEROTONIN 3 ANTAGONIST; TACHYKININ RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ALLODYNIA; COLITIS; CONFERENCE PAPER; CONSTIPATION; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; DRUG PROTEIN BINDING; ENZYME ACTIVATION; HUMAN; HYPERALGESIA; INTESTINE ABSORPTION; IRRITABLE COLON; LOW DRUG DOSE; NOCICEPTIVE STIMULATION; NONHUMAN; OUTCOME ASSESSMENT; PAIN ASSESSMENT; VISCERAL PAIN;

EID: 84880860326     PISSN: 17474124     EISSN: 17474132     Source Type: Journal    
DOI: 10.1586/17474124.2013.820045     Document Type: Conference Paper

References (24)

1. Brierley SM, Hughes PA, Harrington AM, Blackshaw E. Innervation of the gastrointestinal tract by vagal and spinal afferent nerves. In: Physiology of the Gastrointestinal Tract (5th Edition). Johnson LR, Ghishan FK, Kaunitz JD, Merchant JL (Eds). Academic Press, London, UK, 703-731 (2012).
2. Blackshaw LA. Functional targets for pharmacotherapy-an overview. In: Pathophysiology of the Enteric Nervous System: a Basis for Understanding Functional Diseases. Spiller R, Grundy D (Eds). Wiley-Blackwell, NJ, USA (2004).
3. Brierley SM, Carter R, Jones W, Gebhart GF, Blackshaw LA. Splanchnic and pelvic mechanosensory afferents signal different qualities of colonic stimuli in mice. Gastroenterology 127, 166-178 (2004). (Pubitemid 38962285)
4. Brierley SM, Page AJ, Hughes PA et al. Selective role for TRPV4 ion channels in visceral sensory pathways. Gastroenterology 134(7), 2059-2069 (2008). (Pubitemid 351783249)
5. Hughes PA, Brierley SM, Martin CM, Brookes SJ, Linden DR, Blackshaw LA. Post-inflammatory colonic afferent sensitisation: different subtypes, different pathways and different time courses. Gut 58(10), 1333-1341 (2009).
6. Posserud I, Ersryd A, Simrén M. Functional findings in irritable bowel syndrome. World J. Gastroenterol. 12(18), 2830-2838 (2006). (Pubitemid 43805451)
7. Sinhamahapatra P, Saha SP, Chowdhury A, Chakrabarti SK, Ghosh A, Maiti B. Visceral afferent hypersensitivity in irritable bowel syndrome-evaluation by cerebral evoked potential after rectal stimulation. Am. J. Gastroenterol. 96(7), 2150-2157 (2001). (Pubitemid 32660912)
8. Booth CE, Kirkup AJ, Hicks GA, Humphrey PP, Grundy D. Somatostatin sst(2) receptor-mediated inhibition of mesenteric afferent nerves of the jejunum in the anesthetized rat. Gastroenterology 121(2), 358-369 (2001). (Pubitemid 32729383)
9. Sengupta JN, Su X, Gebhart GF. Kappa, but not mu or delta, opioids attenuate responses to distention of afferent fibers innervating the rat colon. Gastroenterology 111(4), 968-980 (1996). (Pubitemid 26327599)
10. Sengupta JN, Medda BK, Shaker R. Effect of GABA(B) receptor agonist on distension-sensitive pelvic nerve afferent fibers innervating rat colon. Am. J. Physiol. Gastrointest. Liver Physiol. 283(6), G1343-G1351 (2002). (Pubitemid 35351122)
11. Camilleri M. Review article: new receptor targets for medical therapy in irritable bowel syndrome. Aliment. Pharmacol. Ther. 31(1), 35-46 (2010).
12. Eutamene H, Bradesi S, Larauche M et al. Guanylate cyclase C-mediated antinociceptive effects of linaclotide in rodent models of visceral pain. Neurogastroenterol. Motil. 22(3), 312-e84 (2010).
13. Johnston JM, Kurtz CB, Macdougall JE et al. Linaclotide improves abdominal pain and bowel habits in a Phase IIb study of patients with irritable bowel syndrome with constipation. Gastroenterology 139(6), 1877-1886 (2010).
14. Chey WD, Lembo AJ, Lavins BJ et al. Linaclotide for irritable bowel syndrome with constipation: a 26-week, randomized, double-blind, placebo-controlled trial to evaluate efficacy and safety. Am. J. Gastroenterol. 107, 1702-1712 (2012).
15. Rao S, Lembo AJ, Shiff SJ et al. A 12-week, randomized, controlled trial with a 4-week randomized withdrawal period to evaluate the efficacy and safety of linaclotide in irritable bowel syndrome with constipation. Am. J. Gastroenterol. 107, 1714-1724 (2012).
16. Quigley EMM, Tack J, Choi HS et al. Randomised clinical trials: linaclotide Phase studies in IBS-C-a prespecified further analysis based on European Medicines Agency-specified endpoints. Aliment. Pharmacol. Ther. 37(1), 49-61 (2013).
17. Brierley SM. Guanylate cyclase-C receptor activation: unexpected biology. Curr. Opin. Pharmacol. 12(6), 632-640 (2012).
18. Bryant AP, Busby RW, Bartolini WP et al. Linaclotide is a potent and selective guanylate cyclase C agonist that elicits pharmacological effects locally in the gastrointestinal tract. Life Sci. 86(19-20), 760-765 (2010).
19. Busby RW, Bryant AP, Bartolini WP et al. Linaclotide, through activation of guanylate cyclase C, acts locally in the gastrointestinal tract to elicit enhanced intestinal secretion and transit. Eur. J. Pharmacol. 649, 328-335 (2010).
20. Castro J, Harrington AM, Hughes PA et al. Mechanism of action for linaclotide induced abdominal pain relief. Gastroenterology 142(Suppl. 5), S699 (2012).
21. Castro J, Harrington AM, Hughes PA et al. Guanylate cyclase C receptor agonists, linaclotide and uroguanylin, modulate intestinal nociception. Neurogastroenterol. Motil. 24(Suppl. 12), 17. (2012).
22. Castro J, Martin C, Hughes PA et al. A novel role of cyclic GMP in colonic sensory neurotransmission in healthy and TNBS-treated mice. Gastroenterology 140(Suppl. 5), S538 (2011).
23. Bueno L, Eutamene H, Gillet M. Effect of oral cyclic GMP on TNBS-induced colitis and visceral hypersensitivity in rats. Am. J. Gastroenterol. 103(S458), Abstract 1175. (2008).
24. Lucas KA, Pitari GM, Kazerounian S et al. Guanylyl cyclases and signaling by cyclic GMP. Pharmacol. Rev. 52(3), 375-414 (2000).